• LAST PRICE
    288.0600
  • TODAY'S CHANGE (%)
    Trending Up0.4700 (0.1634%)
  • Bid / Lots
    222.5000/ 1
  • Ask / Lots
    319.9400/ 2
  • Open / Previous Close
    285.8300 / 287.5900
  • Day Range
    Low 285.7200
    High 288.8300
  • 52 Week Range
    Low 208.6249
    High 288.8300
  • Volume
    406,565
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 287.59
TimeVolumeUTHR
09:32 ET2999285.83
09:36 ET200285.72
09:41 ET363286.25
09:43 ET100286.25
09:45 ET1005286.3
09:48 ET200285.98
09:52 ET1235286.42
09:54 ET1500287.035
09:56 ET1388286.53
10:01 ET186285.98
10:03 ET100286.59
10:08 ET5035286.205
10:10 ET600286.52
10:12 ET107286.245
10:14 ET1000286.225
10:15 ET800286.25
10:17 ET478286.235
10:21 ET1100286.54
10:24 ET100286.27
10:26 ET600286.24
10:28 ET2200286.25
10:30 ET600286.25
10:32 ET400286.25
10:33 ET500286.5
10:35 ET1281286.49
10:37 ET100286.9
10:39 ET200286.75
10:42 ET604287.285
10:44 ET100287.46
10:46 ET1242287.52
10:48 ET700288.07
10:50 ET177288
10:51 ET100287.87
10:55 ET100287.745
10:57 ET1703287.855
11:02 ET2680287.93
11:04 ET100287.92
11:08 ET3840287.15
11:09 ET600286.16
11:11 ET100286.4835
11:15 ET300286.315
11:22 ET400286.26
11:26 ET425286.47
11:29 ET1117286.54
11:31 ET615286.74
11:40 ET300286.62
11:42 ET4179287.05
11:44 ET100286.989
11:45 ET500286.93
11:54 ET600286.953
11:56 ET1100286.83
11:58 ET805287.01
12:00 ET1217287.35
12:02 ET200287.36
12:03 ET100287.24
12:05 ET100287.25
12:12 ET1300287.43
12:14 ET1600287.52
12:16 ET1000287.175
12:23 ET100287.19
12:27 ET940287.4
12:38 ET100287.27
12:41 ET600287.55
12:48 ET1800287.635
12:50 ET700287.63
12:54 ET6287287.565
12:56 ET1402286.935
12:59 ET300287.21
01:03 ET161286.83
01:08 ET100287.07
01:14 ET200287.165
01:15 ET200287.293
01:17 ET430287.075
01:19 ET100287.115
01:24 ET1017286.9
01:26 ET1211286.965
01:30 ET100286.97
01:33 ET1756286.59
01:35 ET136286.84
01:37 ET102286.615
01:42 ET100286.61
01:44 ET1600286.79
01:46 ET400286.87
01:48 ET300287.15
01:51 ET100287.02
01:53 ET1367286.915
01:55 ET100286.91
01:57 ET364286.895
02:00 ET179286.78
02:02 ET1614286.64
02:04 ET300286.58
02:06 ET239286.43
02:09 ET114286.64
02:13 ET813286.8
02:20 ET176286.84
02:22 ET100286.855
02:26 ET1329287.04
02:27 ET200287.37
02:29 ET800287.24
02:31 ET200287.422
02:38 ET400287.37
02:40 ET104287.285
02:44 ET738287.41
02:45 ET600287.61
02:47 ET947287.46
02:49 ET176287.52
02:51 ET1955287.58
02:54 ET3630287.445
03:00 ET200287.69
03:02 ET300287.54
03:03 ET1504287.69
03:07 ET100287.74
03:12 ET562287.895
03:14 ET3100287.905
03:16 ET730287.79
03:18 ET500287.91
03:20 ET449287.875
03:21 ET200287.65
03:23 ET661287.66
03:25 ET275287.51
03:27 ET901287.4
03:32 ET1246287.58
03:36 ET2465287.915
03:38 ET200287.995
03:39 ET200288.11
03:41 ET4181288.2975
03:43 ET836288.36
03:45 ET800288.485
03:48 ET1500288.645
03:50 ET5004288.33
03:52 ET1900287.9
03:54 ET3006287.75
03:56 ET3940287.97
03:57 ET4644287.94
03:59 ET9301288.06
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesUTHR
United Therapeutics Corp
12.8B
13.6x
+8.22%
United StatesMEDP
Medpace Holdings Inc
12.2B
40.1x
+35.10%
United StatesBMRN
Biomarin Pharmaceutical Inc
15.9B
79.0x
---
United StatesNBIX
Neurocrine Biosciences Inc
13.6B
37.2x
+62.04%
United StatesQGEN
Qiagen NV
9.4B
27.8x
+12.66%
United StatesBGNE
Beigene Ltd
17.9B
-21.5x
---
As of 2024-06-15

Company Information

United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.

Contact Information

Headquarters
1000 SPRING STSILVER SPRING, MD, United States 20910
Phone
301-608-9292
Fax
301-608-9291

Executives

Chairman of the Board, Chief Executive Officer
Martine Rothblatt
President, Chief Operating Officer
Michael Benkowitz
Lead Independent Vice Chairman of the Board
Christopher Patusky
Chief Financial Officer, Treasurer
James Edgemond
Executive Vice President, General Counsel, Corporate Secretary
Paul Mahon

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$12.8B
Revenue (TTM)
$2.5B
Shares Outstanding
44.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.54
EPS
$21.13
Book Value
$127.23
P/E Ratio
13.6x
Price/Sales (TTM)
5.1
Price/Cash Flow (TTM)
11.6x
Operating Margin
50.31%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.